CosmicTaco
CosmicTaco

Indian Pharma Giants Bet on Ozempic Copy Amid Revenue Decline

  • Natco Pharma and Dr. Reddy's shift focus to weight-loss drug Ozempic's generic version to counter revenue drop from Revlimid.
  • Natco's shares fell 30% post weak Q3 earnings; Dr. Reddy's profits from Revlimid face future decline.
  • Both companies eye Semaglutide market, with Natco securing exclusivity and Dr. Reddy's planning launches in Canada and emerging markets.

Source: Mint, Mint

Post image
5mo ago
Jobs
One interview, 1000+ job opportunities
Take a 10-min AI interview to qualify for numerous real jobs auto-matched to your profile 🔑
+322 new users this month
No comments yet

You're early. There are no comments yet.

Be the first to comment.

Discover more
Curated from across
Health & Fitness
by BubblyNoodleFounder's Office

Ozempic Reviews Information

Hey Guys, Does anyone know someone who have used Ozempic? Is it available in India? Would love to know more on it and how to get it.